Current
lung cancer diagnosis methods encounter delayed visual
confirmation of tumor foci and low-resolution metrics in imaging findings,
which delays the early treatment of tumors. Here, we developed a potent
lung cancer imaging and treatment strategy centered around a nanotransformational
concept of tumor iron mineralization in situ, which
employs Prussian blue/calcium peroxide nanocomposites as a precursor.
The resultant iron mineralization in tumor cells greatly facilitates
the early and differential diagnosis of lung carcinoma from benign
nodules via medical imaging, meanwhile introducing oxidative stress
to activate the cellular apoptosis and ferroptosis pathways, resulting
in inhibition of the malignant behavior of tumor cells. Tumor-microenvironment-triggered
iron mineralization enables integration of the detection and prevention
of tumor metastasis at its early stages with no assistance of toxic
drugs, which offers a potential solution for the precise management
of lung cancer with ideal outcomes.